Alpha-1 adrenergic receptor, Beta-1 adrenergic receptor, Beta-2 adrenergic receptor (α1-AR, β1-AR, β2-AR)

Alpha-1, beta-1, and beta-2 adrenergic receptors are three major subtypes of adrenergic receptors that mediate physiological responses to the endogenous catecholamines norepinephrine and epinephrine via coupling to G protein-mediated signaling pathways. These receptors are classified as G protein-coupled receptors and are widely distributed in the cardiovascular, respiratory, and other organ systems. - Alpha-1 adrenergic receptors are primarily responsible for smooth muscle contraction and vasoconstriction. - Beta-1 adrenergic receptors are predominantly located in the heart, where they increase heart rate and contractility, and in the kidney, where they stimulate renin release. - Beta-2 adrenergic receptors are primarily involved in bronchodilation and smooth muscle relaxation in various tissues. All three are important therapeutic targets, modulated by agonists or antagonists in a wide range of cardiovascular, respiratory, and other diseases. The specific molecular properties, tissue distribution, structure, and drug selectivity differ for each receptor.

Other names

α1-adrenergic receptorα1-adrenoceptorβ1-adrenergic receptorβ1-adrenoceptorβ2-adrenergic receptorβ2-adrenoceptorAdrenergic receptor (generic/group term)Adrenoceptor

Agonists activate these GPCRs to mimic sympathetic neural activation, leading to vasoconstriction (α1), increased cardiac contractility/heart rate (β1), and bronchodilation (β2). Antagonists (blockers) inhibit receptor activity, reducing sympathetic nervous system effects such as blood pressure, heart rate, and bronchoconstriction.